These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1807968)

  • 1. [Implications of 5-HT2 receptors in the increase of slow wave sleep in healthy volunteers under amoxapine].
    Loas G
    Encephale; 1991 Dec; 17 Spec No 3():423-5. PubMed ID: 1807968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the affinities of amoxapine and loxapine for various receptors in rat brain and the receptor down-regulation after chronic administration].
    Wei HB; Niu XY
    Yao Xue Xue Bao; 1990; 25(12):881-5. PubMed ID: 1966571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers.
    van Laar M; Volkerts E; Verbaten M
    Psychopharmacology (Berl); 2001 Mar; 154(2):189-97. PubMed ID: 11314681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ritanserin-induced changes in sleep-waking phases in rats.
    Kirov R; Moyanova S
    Acta Physiol Pharmacol Bulg; 1995; 21(4):87-92. PubMed ID: 8830880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acute and chronic treatment with amoxapine and cericlamine on the sleep-wakefulness cycle in the rat.
    Maudhuit C; Jolas T; Lainey E; Hamon M; Adrien J
    Neuropharmacology; 1994 Aug; 33(8):1017-25. PubMed ID: 7845548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors.
    Sharpley AL; Elliott JM; Attenburrow MJ; Cowen PJ
    Neuropharmacology; 1994; 33(3-4):467-71. PubMed ID: 7984285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preclinical pharmacology of amoxapine and amitriptyline. Implications of serotoninergic and opiodergic systems in their central effect in rats].
    Gozlan H; Saddiki-Traki F; Merahi N; Laguzzi R; Hamon M
    Encephale; 1991 Dec; 17 Spec No 3():415-22. PubMed ID: 1666997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5-HT2 antagonist ritanserin decreases sleep in cats.
    Sommerfelt L; Ursin R
    Sleep; 1993 Jan; 16(1):15-22. PubMed ID: 8456229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ritanserin, a serotonin-2 receptor antagonist, improves ultradian sleep rhythmicity in young poor sleepers.
    Viola AU; Brandenberger G; Toussaint M; Bouhours P; Paul Macher J; Luthringer R
    Clin Neurophysiol; 2002 Mar; 113(3):429-34. PubMed ID: 11897543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans.
    Sharpley AL; Solomon RA; Fernando AI; da Roza Davis JM; Cowen PJ
    Psychopharmacology (Berl); 1990; 101(4):568-9. PubMed ID: 2117764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of 5-HT2 antagonism on slow wave sleep in major depression: relationship with clinical aspects.
    Staner L; Kempenaers C; Fransolet L; Mendlewicz J
    Acta Psychiatr Belg; 1992; 92(3):182. PubMed ID: 1345435
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shift.
    Kantor S; Jakus R; Bodizs R; Halasz P; Bagdy G
    Brain Res; 2002 Jul; 943(1):105-11. PubMed ID: 12088844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin modulates the sensitivity of 5-hydroxytryptamine-2 receptor-mediated sleep-wakefulness regulation in the rat.
    Dugovic C; Leysen JE; Wauquier A
    Neurosci Lett; 1989 Oct; 104(3):320-5. PubMed ID: 2510097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pharmacologic treatments on the sleep of depressed patients.
    Sharpley AL; Cowen PJ
    Biol Psychiatry; 1995 Jan; 37(2):85-98. PubMed ID: 7718684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The light-dark cycle modulates the effects of ritanserin on sleep-wakefulness patterns in the rat.
    Dugovic C; Leysen JE; Janssen PF; Wauquier A
    Pharmacol Biochem Behav; 1989 Nov; 34(3):533-7. PubMed ID: 2516324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium increases slow wave sleep: possible mediation by brain 5-HT2 receptors?
    Friston KJ; Sharpley AL; Solomon RA; Cowen PJ
    Psychopharmacology (Berl); 1989; 98(1):139-40. PubMed ID: 2498958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT2 receptors are partially involved in the relationship between renin release and delta relative power.
    Brandenberger G; Luthringer R; Muller G; Gronfier C; Schaltenbrand N; Macher JP; Muzet A; Follenius M
    J Endocrinol Invest; 1996 Sep; 19(8):556-62. PubMed ID: 8905480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
    Cohen ML; Schenck KW; Kurz KD
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT2 receptor antagonism and slow-wave sleep in major depression.
    Staner L; Kempenaers C; Simonnet MP; Fransolet L; Mendlewicz J
    Acta Psychiatr Scand; 1992 Aug; 86(2):133-7. PubMed ID: 1529736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
    Costall B; Naylor RJ
    Br J Pharmacol; 1997 Nov; 122(6):1105-18. PubMed ID: 9401775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.